Takahashi T. A neuroeconomic theory of rational addiction and nonlinear time-perception.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 221-225

Koci J, Oberreiter M, Hyspler R, Ticha A, Valis M, Lochman P, Havel E, Ferko A. A positive fluid balance does not deteriorate tissue metabolism during fluid resuscitation of sepsis.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 345-348

Oravec S, Dukát A, Gavorník P, Lovásová Z, Gruber K. Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 317-321

Marcisz C, Kucharz E, Marcisz-Orzel M, Poręba R, Orzel A, Sioma-Markowska U. Changes of poststimulatory plasma renin activity in women with hyperthyroidism or hypothyroidism in relation to therapy.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 301-307

Valis M, Masopust J, Bažant J, Ríhová Z, Kalnická D, Urban A, Zumrová A, Hort J. Cognitive changes in spinocerebellar ataxia type 2.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 354-359

Kovárů H, Kovaru F, Ondráčkova P, Lisá V, Fiserová A. Effect of fluoxetine or adenosine receptor NECA agonist on G-proteins of C6 glioma cells or NK immunocytes.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 274-278

Baszko-Blaszyk D, Ziemnicka K, Waśko R, Pietz L, Waligórska-Stachura J, Gut P, Biczysko M, Sowiński J. Fatal course of cyclic Cushing's disease - lessons from a case.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 238-241

Xu J, Zhao H, Jiang T, Gao Y, Zheng C, Wang B, Qu Y. Granulocytic sarcoma, an undiagnosed leukemia, initially manifested as paralysis.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 234-237

Oravec S, Gruber K, Dostal E, Mikl J. Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 322-327

Romanik M, Nowosielski K, Martirosian G, Poręba R, Sioma-Markowska U. Identification of pregnant women at risk of Streptococcus group B colonisation.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 308-312

Hroudová J, Fisar Z, Korábečný J, Kuča K. In vitro effects of acetylcholinesterase inhibitors and reactivators on Complex I of electron transport chain.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 259-263

Pacini N, Ferrari A, Menozzi M, Borziani F. Melatonin enhances the in vitro action of cytochalasin B on globular resistance and osmotic fragility of erythrocytes.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 292-300

Venclíková Z, Benada O, Joska L. Monitoring of selenium in oral cavity argyria - a clinical and microscopic study.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 286-291

Kozak J, Kobesova A, Vrba I, Steindler J, Kolar P. Peripheral nerve stimulation in intractable neuropathic pain.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 226-233

Očadlík I, Hlinštáková S, Oravec S. Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 360-364

Owecki M, Nikisch E, Miczke A, Pupek-Musialik D, Sowiński J. Serum resistin concentrations are associated with HbA1c in obese non-diabetics, but not in obese diabetics: a cross-sectional human study.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 349-353

Maes M, Galecki P, Verkerk R, Rief W. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 264-273

Velemínsky M, Fuxová A, Sák P. Rare complications of pregnancy: aortic cystic medionecrosis, gallbladder carcinoma, Hodgkin lymphoma.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 242-245

Fang H, Du X, Meng F, Zhou J. SUMO negatively regulates BACE expression.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 313-316

Vrajová M, Peková S, Horácek J, Höschl C. The effects of siRNA-mediated RGS4 gene silencing on the whole genome transcription profile: implications for schizophrenia.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 246-252

Schraml F, Goslar P, Baxter L, Beason-Held L. Thyroid stimulating hormone and cognition during severe, transient hypothyroidism.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 279-285

Ashe K, Chiu W, Khalifa A, Nicolas A, Brown B, De Martino R, Alexander C, Waggener C, Fischer-Stenger K, Stewart J. Vesicular monoamine transporter-1 (VMAT-1) mRNA and immunoreactive proteins in mouse brain.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 253-258

Wójtowicz A, Undas A, Huras H, Musiał J, Rytlewski K, Reroń A, Wilczak M, Jach R. Aspirin resistance may be associated with adverse pregnancy outcomes.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 334-339

Milewicz T, Ryś J, Wójtowicz A, Stochmal E, Jach R, Krzysiek J, Gregoraszczuk E, Huras H, Dziadek O. Overexpression of P53 protein and local hGH, IGF-I, IGFBP-3, IGFBP-2 and PRL secretion by human breast cancer explants.  Neuro Endocrinol Lett. 2011 Jan;  32(3): 328-333